Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver

Ramipril-Induced Liver Injury: Case Report and Review of the Literature

(2013) Antonios Douros et al.   AMERICAN JOURNAL OF HYPERTENSION

Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation

(2013) O. Guillaud et al.   TRANSPLANTATION PROCEEDINGS

The innate immune response during liver inflammation and metabolic disease

(2013) Veerle Bieghs et al.   TRENDS IN IMMUNOLOGY

Mechanism of the Inhibitory Effects ofEucommia ulmoidesOliv. Cortex Extracts (EUCE) in the CCl4-Induced Acute Liver Lipid Accumulation in Rats

(2013) Chang-Feng Jin et al.   International Journal of Endocrinology

Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats

(2012) En-tong Yi et al.   ACTA PHARMACOLOGICA SINICA

Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin–Angiotensin System Inhibitors

(2012) Harikrishna Makani et al.   AMERICAN JOURNAL OF CARDIOLOGY

Inflammation in Alcoholic Liver Disease

(2012) H. Joe Wang et al.   Annual Review of Nutrition

Protective effects of Sonchus asper (L.) Hill, (Asteraceae) against CCl4-induced oxidative stress in the thyroid tissue of rats

(2012) Rahmat Ali Khan   BMC Complementary and Alternative Medicine

The evolving story of macrophages in acute liver failure

(2012) Qiao Yang et al.   IMMUNOLOGY LETTERS

Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis

(2012) Claudia von Montfort et al.   JOURNAL OF HEPATOLOGY

Pathogenesis of Liver Fibrosis

(2011) Virginia Hernandez-Gea et al.   Annual Review of Pathology-Mechanisms of Disease

Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats

(2011) Martins Ekor et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Angiotensin-Converting Enzyme Inhibitors

(2011) Joseph L. Izzo Jr et al.   Journal of Clinical Hypertension

Accelerated CCl4-Induced Liver Fibrosis in Hjv-/- Mice, Associated with an Oxidative Burst and Precocious Profibrogenic Gene Expression

(2011) Giada Sebastiani et al.   PLoS One

The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort

(2010) Barham K. Abu Dayyeh et al.   DIGESTIVE DISEASES AND SCIENCES

Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease

(2010) James E. Nelson et al.   HEPATOLOGY

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

(2010) Herbert Tilg et al.   HEPATOLOGY

Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C

(2009) Jordi Colmenero et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Advances in antifibrotic therapy

(2009) Zahra Ghiassi-Nejad et al.   Expert Review of Gastroenterology & Hepatology

Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model

(2008) Moon Young Kim et al.   JOURNAL OF GASTROENTEROLOGY